1 American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Defi nitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864–74.
2 Sprung CL, Sakr Y, Vincent JL, et al. An evaluation of systemic inflammatory response syndrome signs in the Sepsis Occurrence In Acutely Ill Patients (SOAP) study. Intensive Care Med 2006; 32: 421–27.
3 Lai NA, Kruger P. The predictive ability of a weighted systemic inflammatory response syndrome score for microbiologically confirmed-infection in hospitalised patients with suspected sepsis. Crit Care Resusc 2011; 13: 146–50.
4 Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250–56.
5 Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 2011; 29: 139–62.
6 Nathan C, Ding A. Nonresolving inflammation. Cell 2010; 140: 871–82.
7 Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med 2011; 208: 2581–90.
8 Czura CJ. “Merinoff Symposium 2010: sepsis”–speaking with one voice. Mol Med 2011; 17: 2–3.
9 Vincent JL, Moreno R. Clinical review: scoring systems in the critically ill. Crit Care 2010; 14: 207.
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.